Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
Co-Diagnostics joint venture CoSara initiated clinical studies in India for a tuberculosis test on its PCR platform.
Co-Diagnostics
Co-Diagnostics is a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests. Joint venture CoSara initiated clinical studies in India for a tuberculosis test on its PCR platform.
Company Info
Upcoming Milestones & Key Dates
Q4 2026
Clinical
India TB test clinical results
Clinical Development Pipeline
CoSara TB Test
Target: PCR-based diagnosticCOVID-19 Test
Target: PCR-based diagnosticOther infectious disease tests
Target: PCR-based diagnosticsRecent News
Leadership Team
Dwight Egan
Chief Executive Officer
To be confirmed
Chief Scientific Officer
To be confirmed
Chief Financial Officer
Careers & Job Openings